BRD2 and polycystic ovary syndrome: At the end of the modelling period, PCOS-like serological alterations were confirmed by elevated luteinizing hormone (LH) to follicle-stimulating hormone (FSH) ratios (p = 0.0129) and increased testosterone levels (p = 0.0390) (Figure 1D).